 Joint Committee on Pharmaceutical Excipients (Conference Call) |
|
| Name | Joint Committee on Pharmaceutical Excipients (Conference Call) |
| Time | Friday, 11 May 2012, 08:30am to 11:00am EDT |
| Location | Teleconference |
| Description | Teleconference details:
• Phone number: 1-866-740-1260 (US & Canada)
• Access code (for phone and web): 9135159
International Access:
• France: 0800942408 (Toll Free) remove • Switzerland: 0800705351 (Toll Free) remove
• United Kingdom: 08004960576 (Toll Free) remove |
| Agenda | Continue review and discussion of input from FDA, IPEC, OC-OMPQ, IMoore, CMoreton |
| Submitter | Person 1696 |
| Group | Joint Committee on Pharmaceutical Excipients |
| Access |
This event is visible to Joint Committee on Pharmaceutical Excipients
and shared with:
|
| Counts toward voter eligibility | no |
| Public URL | http://standards.nsf.org/apps/group_public/event.php?event_id=1613 |
| Meeting Attendees Spreadsheet | |||
| Company | Name  |
Interest Category | Role |
| Novartis Pharma AG | Jeffrey Brambora | User | Vice chair |
| Huber Engineered Materials | Dale Carter | Industry | Member |
| NSF International | General Interest | Secretariat | |
| Croda Europe Ltd. | Iain Moore | Industry | Member |
| FinnBrit Consulting | Chris Moreton | User | Member |
| IPEA, Inc. | Irwin Silverstein | User | Member |
| Dow Corning | Katherine Ulman | Industry | Member |
| IPEC Americas | Ann Van Meter | Industry | Member |
| Food and Drug Administration | Steven Wolfgang | Public Health / Regulatory | Member |
| Meeting Statistics | |
| Quorum rule | 51% of voting members |
| Achieved quorum | yes |
| Individual Attendance | Contributing Members: 9 of 16 (56%) Voting Members: 8 of 15 (53%) (used for quorum calculation) |
| Company Attendance | Contributing Companies: 9 of 15 (60%) Voting Companies: 8 of 14 (57%) |